(Updates with the stock move in the headline and the first paragraph.)
Nutex Health (NUTX) shares were up more than 42% in premarket activity Tuesday after the company reported overnight a swing back into the black as sales more than tripled in Q4.
The company reported Q4 diluted earnings of $11.12 per share late Monday, compared to a loss of $7.47 a year earlier.
Revenue for the quarter that ended Dec. 31 was $257.6 million, up from $69.7 million.
Price: 66.98, Change: +19.95, Percent Change: +42.42
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.